Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Retinal Cases & Brief Reports|September 14, 2023
PARADOXICAL EXACERBATION OF SCLEROUVEITIS AFTER RITUXIMAB INFUSIONDaphne P C Vergouwen, Maud A W Hermans, Lise SelsFrontiers in Ophthalmology|July 10, 2024
Scleritis in rheumatoid arthritis: Before and during biologic eraDaphne P C Vergouwen, Pascal H P de Jong, Marco W J Schreurs, et al.Investigative Ophthalmology & Visual Science|December 8, 2023
Tear Fluid Inflammatory Proteome Analysis Highlights Similarities Between Keratoconus and Allergic ConjunctivitisMarlies Gijs, Tuneille I Adelaar, Daphne P C Vergouwen, et al.Investigative Ophthalmology & Visual Science|March 17, 2023
Scleral Proteome in Noninfectious Scleritis Unravels Upregulation of Filaggrin-2 and Signs of NeovascularizationDaphne P C Vergouwen, Josianne C Ten Berge, Coskun Guzel, et al.Journal of Ophthalmic Inflammation and Infection|August 26, 2022
Destructive inflammatory reaction after an autologous retinal pigment epithelium and choroid transplantation: no detection of an auto-immune responseSaskia H M van Romunde, Daphne P C Vergouwen, Daniela Iacovello, et al.Ophthalmology Science|December 6, 2023
Potential Biomarkers for Noninfectious Scleritis Identified by Serum and Tear Fluid ProteomicsDaphne P C Vergouwen, P Martijn Kolijn, Joeri de Hoog, et al.Scientific Reports|March 18, 2023
Evaluation of pre-processing methods for tear fluid proteomics using proximity extension assaysDaphne P C Vergouwen, Amber J Schotting, Tanja Endermann, et al.Ocular Immunology and Inflammation|July 12, 2023
Long-Term Follow-Up of Patients with Scleritis After Rituximab Treatment Including B Cell MonitoringKiki van Bilsen, Daphne P C Vergouwen, Mirjam E J van Velthoven, et al.Journal of Autoimmunity|February 18, 2024
The enigma of sclera-specific autoimmunity in scleritisDaphne P C Vergouwen, Adriaan A van Beek, Joeri de Hoog, et al.Pageof 1